Medicines List

Description

Indapamide is a non-thiazide sulphonamide diuretic drug, generally used in the treatment of hypertension, as well as decompensated cardiac failure.

Indications

Indicated for treatment of patients with arterial hypertension – primary and secondary, including in patients with chronic renal failure, as single therapy or in combination with other anti-hypertensive drugs for prolonged periods.

Subject to medical prescription

Pharmaceutical form: 1.5 mg x 30 prolonged-release tablets

NHIF code: CF 607

ICD: I10; I11.0, I11.9, I12.0, I12.9, I13.0, I13.1, I13.2

Description

Anastrozole is a powerful and highly selective non-steroidal aromatase inhibitor used to treat breast cancer after surgery and for metastases in both pre and post-menopausal women.

Indications

-  Treatment of advanced breast cancer in postmenopausal women. Efficacy has not been demonstrated in oestrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen.

-  Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer.

-  Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

Subject to medical prescription

Pharmaceutical form: 1 mg x 28 film-coated tablets

NHIF code: LF156 ICD: C50

Description

Pramipexole is a non-ergoline dopaminergic agonist that highly selectively and specifically binds to D2-dopamine receptors and in particular has an affinity to D3 subtype, and has full intrinsic activity.

Indications

Peximyr is indicated in adults for treatment of the signs and symptoms of idiopathic Parkinson’s disease, alone (without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or “on off” fluctuations).

Peximyr is indicated in adults for symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in doses up to 0.54 mg of base (0.75 mg of salt)

Subject to medical prescription

Pharmaceutical form: 0.18 mg (0.25 mg salt) x 30 tablets

NHIF code: NF 683          ICD: G20

Pharmaceutical form: 0.7 mg (1 mg salt) x 30 tablets

NHIF code: NF 685          ICD: G20

Description

Clopidogrel is an oral, thienopyridine class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.

Indications

PlaquEx is indicated for the prevention of atherothrombotic events in:

•        Patients suffering from myocardial infarction (from a few days until less than 35 days), Ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

•        Patient suffering from acute coronary syndrome:

– Acute coronary syndrome without ST segment elevation (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA).

– ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

Subject to medical prescription

Pharmaceutical form: 75 mg x 30 film-coated tablets

NHIF code: BF 198

ICD: I20.0, I20.1, I20.8 /after stent placement, after acute myocardial infarction with or without ST-elevation/; I69.3; I69.8; I73.1